Systematic review of physical and chemical compatibility of commonly used medications administered by continuous infusion in intensive care units

被引:92
作者
Kanji, Salmaan [1 ,2 ,3 ]
Lam, Jason [1 ]
Johanson, Christel [1 ]
Singh, Avinder [1 ]
Goddard, Rob [1 ]
Fairbairn, Jennifer [1 ]
Lloyd, Tammy [1 ]
Monsour, Danny [3 ]
Kakal, Juzer [3 ]
机构
[1] Ottawa Hosp, Dept Pharm, Ottawa, ON, Canada
[2] Ottawa Hosp, Dept Crit Care, Ottawa, ON, Canada
[3] Ottawa Hosp Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada
关键词
physical compatibility; chemical compatibility; drug infusions; intensive care unit; Y-SITE INJECTION; PARENTERAL NUTRIENT SOLUTIONS; INTRAVENOUS ADMIXTURE COMPATIBILITY; AMIODARONE HYDROCHLORIDE INJECTION; PROPOFOL INJECTABLE EMULSION; SODIUM-CHLORIDE INJECTION; VISUAL COMPATIBILITY; MORPHINE-SULFATE; MIDAZOLAM HYDROCHLORIDE; ESMOLOL HYDROCHLORIDE;
D O I
10.1097/CCM.0b013e3181e8adcc
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective: To quantify the physical and chemical stability data published for commonly used continuously infused medications in the intensive care unit and to evaluate the quality of the studies providing these data. Data Sources and Study Selection: We conducted a systematic electronic literature search of MEDLINE, EMBASE, and International Pharmaceutical Abstracts as well as the references of electronic drug compatibility textbooks for all English and French language research publications evaluating the physical compatibility or chemical stability of the 820 possible two-drug combinations of 41 commonly used drugs in an adult intensive care unit. Data Extraction and Synthesis: A total of 93 studies comprised of 86 (92%) studies evaluating physical compatibility and 35 (38%) studies evaluating chemical compatibility of at least one drug combination of interest were included. Physical and/or chemical compatibility data exist for only 441 of the possible 820 two-drug combinations (54%), whereas chemical compatibility data exist for only 75 (9%) of the possible combinations. Of the 441 combinations for which compatibility data are available, 67 (15%) represent incompatible combinations and 39 (9%) had conflicting data in which both compatible and incompatible data were identified. Conclusions: Physical compatibility studies that provide the basis for y-site compatibility are lacking for commonly used medications in intensive care unit patients and may contribute to unsafe medication practices. Furthermore, the heterogeneity in the methodology of these studies likely contributes to the common finding of conflicting data for specific combinations of drugs. Future studies should apply similar methodologic and reporting principles to be able to reproduce and compare outcomes both clinically and in the laboratory. (Crit Care Med 2010; 38:1890-1898)
引用
收藏
页码:1890 / 1898
页数:9
相关论文
共 107 条
[1]   Stability of milrinone lactate in the presence of 29 critical care drugs and 4 i.v. solutions [J].
Akkerman, SR ;
Zhang, HZ ;
Mullins, RE ;
Yaughn, K .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1999, 56 (01) :63-68
[2]   COMPATIBILITY OF VARIOUS ADMIXTURES WITH SECONDARY ADDITIVES AT Y-INJECTION SITES OF INTRAVENOUS ADMINISTRATION SETS .2. [J].
ALLEN, LV ;
STILES, ML .
AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1981, 38 (03) :380-381
[3]   COMPATIBILITY OF VARIOUS ADMIXTURES WITH SECONDARY ADDITIVES AT Y-INJECTION SITES OF INTRAVENOUS ADMINISTRATION SETS [J].
ALLEN, LV ;
LEVINSON, RS ;
PHISUTSINTHOP, D .
AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1977, 34 (09) :939-943
[4]   Compatibility of ketamine hydrochloride and fentanyl citrate in polypropylene syringes [J].
Ambados, F ;
Brealey, J .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2004, 61 (14) :1438-+
[5]   VISUAL COMPATIBILITY OF 30 ADDITIVES WITH A PARENTERAL NUTRIENT SOLUTION [J].
ATHANIKAR, N ;
BOYER, B ;
DEAMER, R ;
HARBISON, H ;
HENRY, RS ;
JURGENS, R ;
METT, C ;
STURGEON, R ;
VANLEUVEN, M ;
WELCO, A .
AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1979, 36 (04) :511-513
[6]   STABILITY OF ESMOLOL HYDROCHLORIDE IN INTRAVENOUS SOLUTIONS [J].
BAASKE, DM ;
DYKSTRA, SD ;
WAGENKNECHT, DM ;
KARNATZ, NN .
AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1994, 51 (21) :2693-2696
[7]   COMPATIBILITY OF HEPARIN SODIUM AND MORPHINE-SULFATE [J].
BAKER, DE ;
YOST, GS ;
CRAIG, VL ;
CAMPBELL, RK .
AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1985, 42 (06) :1352-1355
[8]   COMPATIBILITY OF TOTAL NUTRIENT ADMIXTURES AND SECONDARY CARDIOVASCULAR MEDICATIONS [J].
BAPTISTA, RJ ;
DUMAS, GJ ;
BISTRIAN, BR ;
CONDELLA, F ;
BLACKBURN, GL .
AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1985, 42 (04) :777-778
[9]   Visual compatibility of vasopressin with other injectable drugs [J].
Barker, B ;
Feddema, S ;
Rusho, WJ ;
Dengg, R .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2005, 62 (19) :1969-+
[10]  
Bhatt-Mehta V, 1990, J Perinatol, V10, P129